{"disease":{"id":"neoadjuvant-treatment-for-her2-positive-er-positive-breast-cancer","name":"neoadjuvant treatment for her2 positive er positive breast cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04858516","title":"Neoadjuvant Treatment With Palbociclib and Exemestane Plus Trastuzumab and Pyrotinib in Estrogen Receptor (ER)-Positive, HER2-positive Breast Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":57,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}